Oncorad Group

What Oncorad Group does

Oncorad Group is a Casablanca-headquartered, founder-owned private healthcare group founded in 2000 by Professor Redouane Samlali and Dr. Omar Hajji, organized around three brands: Littoral Clinic (oncology centers), Oceanic Clinic (multidisciplinary clinics), and Vital Radiology (diagnostic imaging). The group operates more than eight facilities across Morocco — in Casablanca, Marrakech, Tanger, Agadir, and Safi — delivering cancer care (medical oncology, chemotherapy, radiotherapy, brachytherapy, bone marrow transplant), advanced surgery including robotic-assisted procedures, interventional radiology, nuclear medicine (PET-Scan, iratherapy), cardiology, gynecology-obstetrics, and 24/7 emergency services.

The group's technology stack centers on capital-intensive equipment that is unique in Morocco and rare across Africa, including the Da Vinci robotic surgical system, CyberKnife, Novalis TX, Halcyon IMRT, PET-Scan, a Cone Beam CT interventional radiology suite, and a tele-surgery network linking Casablanca with Tanger and Shanghai. The group claims first-in-Africa status for robotic surgery (June 2024), a world-record 12,000 km remote prostatectomy (November 2024), and first cryoablation in Morocco and North Africa (2025).

Oncorad generates revenue on a fee-for-service basis through direct patient acquisition at its owned facilities, supplemented by referrals from general practitioners and institutional partnerships within the Moroccan healthcare system. The group also targets medical tourists. Pricing is quoted case-by-case and is not publicly disclosed; the customer base spans oncology, cardiology, women's health, surgical, and diagnostic imaging patients across Morocco. No external private equity, venture capital, or institutional investor is referenced in available materials, and the group remains under founder and executive leadership.

Name

Oncorad Group

Legal name

Oncorad Group

Website

https://oncoradgroup.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Oncorad Group is a Casablanca-headquartered private healthcare group founded in 2000 that operates oncology, multidisciplinary, and imaging clinics across Morocco, delivering cancer care, robotic surgery, advanced radiotherapy, and interventional radiology to Moroccan patients and medical tourists.

Ownership category

akta.pro rank

Product category

Oncology and Cancer Care Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (6211)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC)

Keywords

• Oncology services
• Cancer treatment
• Radiation therapy
• Robotic surgery
• Diagnostic imaging

Headquarters

HQ city

Casablanca

HQ country

Morocco

HQ region

Africa

Offices12 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Consultation and Treatment Services: Fee-for-service revenue from patient consultations, diagnostic services, medical treatments, and surgical procedures across all specialty areas including oncology, cardiology, gynecology, and general surgery.
2. Radiology and Medical Imaging Services: Revenue from diagnostic imaging services including MRI, CT scan, mammography, ultrasound, interventional radiology, and nuclear medicine examinations performed at Vital Radiology centers.
3. Radiation Oncology and Chemotherapy: Revenue from radiotherapy treatments (CyberKnife, Novalis TX, Halcyon, stereotactic radiation, brachytherapy) and chemotherapy administration including day hospital services.
4. Robotic Surgery Procedures: Revenue from advanced robotic surgical procedures across multiple specialties including urology, gynecology, digestive surgery, thoracic surgery, and pediatrics.
5. Nuclear Medicine and Irratherapy: Revenue from nuclear medicine diagnostics (PET-scan, scintigraphy) and therapeutic treatments including radioactive iodine therapy for thyroid conditions and cancer.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Oncorad Group is a Moroccan private healthcare provider that delivers comprehensive cancer prevention, diagnosis, and treatment services through three brands: Littoral Clinic (oncology centers), Oceanic Clinic (multidisciplinary clinics), and Vital Radiology (imaging). Its service portfolio spans robotic surgery, precision radiotherapy (CyberKnife, Novalis TX, Halcyon), chemotherapy, nuclear medicine, interventional radiology, bone marrow transplant, cardiology, gynecology-obstetrics, and neonatology, delivered across owned facilities in Casablanca, Marrakech, Tanger, and Safi.

Product overview

Oncorad Group is a Moroccan healthcare group founded in 2000, organized around three main brands: Littoral Clinic (oncology centers), Oceanic Clinic (multidisciplinary clinics), and Vital Radiology (radiology and advanced imaging). The group offers comprehensive cancer care including oncology, robotic surgery, radiotherapy (Cyberknife, Novalis TX, Halcyon), nuclear medicine, interventional radiology, chemotherapy, and hematology/bone marrow transplant. The group operates multiple facilities across Morocco including Casablanca, Marrakech, Tangier, Safi, and Agadir. Oncorad Group is recognized as a pioneer in cancer prevention and treatment in Morocco and was the first in Africa to introduce robotic surgery.

Differentiator

Problem solved

Functional benefit

Brands

• Littoral Clinic: Dedicated to oncology centers specializing in cancer prevention and treatment.
• Oceanic Clinic
• Vital Radiology

Products and services

• Robotic Surgery Program Robotic-assisted surgical procedures using the Da Vinci platform, led by Dr Youness Ahallal, spanning urology (prostate, kidney, bladder), gynecology, digestive surgery, thoracic surgery, ENT, and pediatric surgery. First and only robotic surgery program in Morocco and Africa with 450+ interventions performed in two years.
• Radiation Therapy (CyberKnife, Novalis TX, Halcyon) Precision external beam radiation therapy delivered via CyberKnife robotic radiosurgery, Novalis TX stereotactic radiosurgery, and Halcyon intensity-modulated radiotherapy systems across Littoral Clinic (Casablanca) and Centre d'Oncologie Majorelle (Marrakech). Combines cranial and extracranial stereotactic treatments with high-precision IMRT.
• Chemotherapy and Day Hospital Services Day-hospital chemotherapy administration and medical oncology services for solid tumors and hematologic malignancies, delivered in dedicated chemotherapy suites with capacity for 32 ambulatory chairs at the Marrakech facility.
• Nuclear Medicine (PET-Scan and Scintigraphy) Functional imaging and metabolic diagnostics using PET-Scan and gamma camera scintigraphy for early tumor detection, staging, and treatment response evaluation across Oncorad's oncology centers.
• Iratherapy (Radioactive Iodine Therapy) Radioactive iodine-131 (I-131) treatment for thyroid cancer and other thyroid conditions, delivered in dedicated lead-shielded radioprotected rooms with 5 iratherapy chambers at Littoral Clinic.
• Interventional Radiology and Cryoablation Minimally invasive image-guided procedures including biopsies, drainages, infiltrations, embolizations, and tumor ablations (including cryoablation at -160°C). Equipped with Cone Beam CT, ultra-thin micro-catheters, and image fusion technology. First cryoablation in Morocco and North Africa performed in 2025.
• Bone Marrow Transplant (Autologous Stem Cell) Autologous hematopoietic stem cell transplantation for leukemia and other blood cancers, delivered in dedicated sterile transplant rooms (4 at Littoral Clinic in Casablanca and 3 at Majorelle Center in Marrakech).
• Diagnostic Imaging (Vital Radiology) Comprehensive diagnostic imaging including MRI, mammography with tomosynthesis, ultrasound, Doppler, CT scan, pediatric imaging, and interventional radiology procedures via Vital Radiology centers in Casablanca (Ain Diab and Cherifa). Deployment of GE Revolution Ascend CT scanner in 2025.
• Cardiology, Gynecology-Obstetrics and Multidisciplinary Surgical Care Multidisciplinary specialty care delivered through Oceanic Clinic locations, covering interventional cardiology, gynecology-obstetrics, neonatology, neurosurgery, trauma surgery, gastro-enterology, urology with robotic assistance, and 24/7 emergency services. Category 3 mother-child services are available at Safi.

Quantifiable outcome

• 450+ robotic surgeries performed in 2 years with 81.6% urology success rate and 88% radical prostatectomy procedures
• +8 more outcomes

Named customers6 records

Segments7 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Centre Hospitalier Universitaire Ibn Sina (CHU Ibn Sina): Morocco's largest public teaching hospital network in Rabat, providing oncology and specialty inpatient services; competes with Oncorad for advanced cancer cases and physician talent within the domestic healthcare system.
• Institut National d'Oncologie (INO): Rabat-based national oncology institute handling large cancer patient volumes in Morocco; comparable to Oncorad's Littoral Clinic and Majorelle Center as a fellow specialty cancer-care provider.
• Apollo Hospitals: India's largest private hospital chain with significant oncology, robotic surgery, and bone marrow transplant programs; comparable as a large multi-site specialty provider in an emerging market.
• Burjeel Holdings: UAE-listed healthcare group with specialty oncology centers and advanced radiation therapy; comparable as a regional specialty provider with multi-site growth strategy in MENA.
• Saudi German Hospital Group: Large private hospital group across MENA with multi-specialty and oncology services; comparable as a regional private specialty hospital network expanding across emerging markets.
• Netcare Limited: Largest private hospital group in South Africa offering oncology, surgery, and imaging services; comparable as an emerging-market private specialty hospital operator at greater scale.
• Acibadem Healthcare Group: Turkey-headquartered private hospital network with oncology, robotic surgery, and radiation therapy across multiple countries; comparable as a multi-site specialty hospital operator expanding in MENA and Balkans.

Direct peers

• Clemenceau Medical Center (CMC): UAE-based specialty hospital with advanced oncology, robotic surgery, and advanced imaging; directly comparable to Oncorad as a private specialty hospital offering premium cancer care in the MENA region.
• Healthcare Global Enterprises (HCG): India-headquartered network of dedicated oncology specialty hospitals with advanced radiation and surgical oncology; directly comparable to Oncorad as a multi-city cancer-specialty hospital operator.

Regional players

• King Faisal Hospital Kigali: Tertiary specialty hospital in Rwanda offering advanced oncology and surgery services in East Africa; comparable as an African specialty provider addressing regional gaps in advanced cancer care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@oncoradgroupe1437
• Facebookfacebook.com/Oncorad-groupe-100063675036902
• LinkedInlinkedin.com/company/oncorad-group

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oncorad Group